RXII - .42 Pre-market now at .44/.448 RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell Transfer at SITC 2018 https://c.stockcharts.com/c-sc/sc?s=RXII&p=D&b=5&g=0&i=t1557824899c&r=1541596049108